Cas:189628-39-5 3-Fluoro-5-methylbenzaldehyde manufacturer & supplier

We serve Chemical Name:3-Fluoro-5-methylbenzaldehyde CAS:189628-39-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Fluoro-5-methylbenzaldehyde

Chemical Name:3-Fluoro-5-methylbenzaldehyde
CAS.NO:189628-39-5
Synonyms:7699713;Benzaldehyde,3-fluoro-5-methyl;5-Fluoro-m-tolualdehyde;VHR CF E1;Benzaldehyde, 3-fluoro-5-methyl-;5-fluoro-3-methylbenzaldehyde;3-Fluoro-5-methylbenzaldehyde
Molecular Formula:C8H7FO
Molecular Weight:138.139
HS Code:2913000090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:197.6±20.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.535
PSA:17.07000
Exact Mass:138.048096
LogP:2.35

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 7699713 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Fluoro-5-methylbenzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Fluoro-m-tolualdehyde Use and application,VHR CF E1 technical grade,usp/ep/jp grade.


Related News: Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers. 3-Fluoro-5-methylbenzaldehyde manufacturer The U.K. government previously purchased more than 380 million rapid tests from Innova, to help set up programs capable of screening millions of people per day—in the run-up to offering free COVID-19 testing nationwide at least twice per week. 3-Fluoro-5-methylbenzaldehyde supplier Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula. 3-Fluoro-5-methylbenzaldehyde vendor As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. 3-Fluoro-5-methylbenzaldehyde factory Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula.